You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
Hello, D.C. Diagnosis readers. The Senate Finance Committee is gearing up to hold new hearings on reducing the price of prescription drugs. Here’s a factoid that’ll make you scream into your hands about Washington gridlock: It’s been more than three years since pharmaceutical CEOs testified before that very committee, on this very issue. Oh, how young and innocent we were back then. I’m at nicholas.florko@statnews.com.